Results 81 to 90 of about 17,572 (227)

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)

open access: yesViruses, 2019
The US Food and Drug Administration issued a black box warning related to the risk of reactivation of overt/occult hepatitis B virus (HBV) infection during direct acting-antivirals (DAA) treatment. This review evaluated the prevalence of HBV reactivation
Mariantonietta Pisaturo   +4 more
doaj   +1 more source

Seropositivity of Hepatitis B virus and Hepatitis C virus dual Infection among blood donors in Nyala Teaching Hospital [PDF]

open access: yes, 2009
The aim of this study was to determine the seropositivity of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) dual infection among blood donors in Nyala Teaching Hospital, which is the biggest (400 beds) hospital in great Dar Fur of Western Sudan. 400
Mustafa Abou, Yassir Eltahir
core   +1 more source

Safe and Localized Lentiviral Gene Delivery via Injectable Mesoporous Scaffolds for Potent Antitumor Immunity

open access: yesAdvanced Materials, Volume 38, Issue 25, 4 May 2026.
This work introduces an injectable mesoporous silica rod scaffold that confines lentiviral vectors to the injection site, enabling localized dendritic cell recruitment and transduction. The platform sustains antigen expression, promotes robust T‐cell activation, and enhances antitumor immunity.
Thanh Loc Nguyen   +12 more
wiley   +1 more source

The Investigation of Occult Hepatitis B Infection in Hemodialysis, Peritoneal Dialysis, and Predialysis Patients by the Polymerase Chain Reaction Method

open access: yesTurkish Journal of Nephrology, 2019
The presence of hepatitis B virus DNA in case of negative hepatitisBsurface antigen in serumis known as occult hepatitis B.Although the exact prevalance is not known, there are many reports indicating that occult hepatitis B is more frequently ...
Mürüvvet DOĞUKAN   +2 more
doaj  

Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta-analysis of prophylaxis management [PDF]

open access: yes, 2017
Hepatitis B virus (HBV) reactivation during or after chemotherapy in patients with breast cancer has become a remarkable clinical problem. Prophylactic nucleos(t)ide analogues (NAs) are recommended for patients with breast cancer who are hepatitis B ...
Gong, Chang   +6 more
core   +2 more sources

Genetic variation of occult hepatitis B virus infection

open access: yesWorld Journal of Gastroenterology, 2016
Occult hepatitis B virus infection (OBI), characterized as the persistence of hepatitis B virus (HBV) surface antigen (HBsAg) seronegativity and low viral load in blood or liver, is a special form of HBV infection. OBI may be related mainly to mutations in the HBV genome, although the underlying mechanism of it remains to be clarified.
Hui-Lan, Zhu   +3 more
openaire   +2 more sources

Immunotherapy and Breast Reconstruction: Opportunities, Challenges, and Future Directions

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Immunotherapy is transforming breast cancer management, but it also presents new challenges for surgical and reconstructive practice. This review summarizes current evidence on immune checkpoint inhibitors, perioperative safety, and immune‐related adverse events, highlighting their impact on surgical timing, postoperative recovery, and ...
Shuang Li   +6 more
wiley   +1 more source

Diagnostic strategy for occult hepatitis B virus infection

open access: yesWorld Journal of Gastroenterology, 2011
In 2008, the European Association for the study of the liver (EASL) defined occult hepatitis B virus infection (OBI) as the "presence of hepatitis B virus (HBV) DNA in the liver (with detectable or undetectable HBV DNA in the serum) of individuals testing hepatitis B surface antigen (HBsAg) negative by currently available assays".
Sara, Ocana   +3 more
openaire   +2 more sources

Hepatitis C virus and hepatitis B virus in indolent lymphomas: Prospective data from the international observational NF10 study

open access: yes
British Journal of Haematology, EarlyView.
Luca Arcaini   +25 more
wiley   +1 more source

PLA2R‐Positive Membranous Nephropathy and AA Amyloidosis in an Ethiopian Patient With Chronic Hepatitis B: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT The coexistence of primary phospholipase A2 receptor positive membranous nephropathy and AA amyloidosis in a patient with chronic hepatitis B is an exceedingly rare triad presenting a profound diagnostic and therapeutic challenge. A 38‐year‐old Ethiopian man with nephrotic syndrome and chronic hepatitis B had dual pathology on renal biopsy ...
Betelhem Abreham   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy